Bioregenx, Inc. financial data

Symbol
BRGX on OTC
Location
7407 Ziegler Road, Chattanooga, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 7.36 % -47.4%
Quick Ratio 3.24 % -42%
Debt-to-equity -123 % -461%
Return On Equity 532 %
Return On Assets -2.29K % -6275%
Operating Margin -965 % -430%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 962M shares +0.57%
Common Stock, Shares, Outstanding 962M shares +0.57%
Entity Public Float 5.59M USD +31.6%
Common Stock, Value, Issued 962K USD +0.57%
Weighted Average Number of Shares Outstanding, Basic 961M shares +0.45%
Weighted Average Number of Shares Outstanding, Diluted 961M shares +0.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.93M USD -24.6%
Cost of Revenue 422K USD -50%
Research and Development Expense -33K USD -168%
Operating Income (Loss) -18.6M USD -300%
Nonoperating Income (Expense) -522K USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.75M USD -546%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -18.9M USD -285%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 83.6K USD -26.7%
Accounts Receivable, after Allowance for Credit Loss, Current 62.6K USD +222%
Inventory, Net 109K USD -31.1%
Other Assets, Current 49.1K USD -33.1%
Assets, Current 273K USD -26.4%
Property, Plant and Equipment, Net 170K USD -20.4%
Intangible Assets, Net (Excluding Goodwill) 17.1M USD
Goodwill 7.11M USD
Other Assets, Noncurrent 0 USD -100%
Assets 1.17M USD -93.3%
Accounts Payable, Current 460K USD -6.71%
Employee-related Liabilities, Current 48K USD
Accrued Liabilities, Current 381K USD -10.8%
Liabilities, Current 3.93M USD +11.8%
Liabilities 4.81M USD +26.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.22K USD -1269%
Retained Earnings (Accumulated Deficit) -36.1M USD -110%
Stockholders' Equity Attributable to Parent -3.65M USD -127%
Liabilities and Equity 1.17M USD -93.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37.7K USD
Net Cash Provided by (Used in) Financing Activities -10.4K USD -104%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 962M shares +0.57%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 25.2K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.9K USD -33%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.2K USD +693%
Deferred Tax Assets, Valuation Allowance 3.32M USD +128%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.9M USD -285%
Deferred Tax Assets, Operating Loss Carryforwards 1.37M USD +94.3%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 31.5M USD +5.75%
Amortization of Intangible Assets 562K USD
Depreciation, Depletion and Amortization 521K USD +937%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 72.1K USD +6.74%